Linked Life Data

11133837

Source:http://linkedlifedata.com/resource/pubmed/id/11133837

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11133837rdf:typepubmed:Citationlld:pubmed
pubmed-article:11133837lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:11133837lifeskim:mentionsumls-concept:C0016411lld:lifeskim
pubmed-article:11133837lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:11133837lifeskim:mentionsumls-concept:C1442161lld:lifeskim
pubmed-article:11133837lifeskim:mentionsumls-concept:C0205100lld:lifeskim
pubmed-article:11133837lifeskim:mentionsumls-concept:C1157288lld:lifeskim
pubmed-article:11133837lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:11133837lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:11133837pubmed:issue1lld:pubmed
pubmed-article:11133837pubmed:dateCreated2001-1-26lld:pubmed
pubmed-article:11133837pubmed:abstractTextMethotrexate (MTX), a folate antagonist with multiple enzymatic targets, is used in the treatment of malignancies as well as in autoimmune and chronic inflammatory diseases, and ZD1694 (tomudex), a water-soluble quinazoline specific inhibitor of thymidylate synthase (TS), is used in the treatment of adenocarcinomas. In this study, we investigated the effects of these folate analogues on superantigen (SAg)-reactive peripheral T cells in vivo. In BALB/c mice, staphylococcal enterotoxin B (SEB)-induced cytokine secretion, IL-2R (CD25) expression and early deletion of a fraction of SEB-reactive V(beta)8(+) T cells were not impaired by either MTX (7 mg/kg/day) or tomudex (5 mg/kg/day). However, both MTX and tomudex prevented V(beta)8-selective T cell expansion and accelerated their peripheral elimination. Administration of thymidine (500 mg/kg/12 h) completely abrogated this effect, indicating that inhibition of TS but not that of other folate-dependent enzymes was the main mechanism involved. Furthermore, a marked increase of apoptotic cells restricted to the V(beta)8(+) T cell subset indicated that proliferation inhibition was associated with apoptosis. In contrast with peripheral V(beta)8(+) T cell deletion, MTX and tomudex did not prevent the increase of V(beta)8(+) thymocytes triggered by SEB. Experiments in C57BL/6-lpr/lpr mice further demonstrated that deletion of V(beta)8(+) T cells induced by folate analogues was independent of Fas-Fas ligand interaction. Our results provide evidence that folate analogues may selectively delete dividing peripheral T cells through TS inhibition, but do not interfere with other events triggered by SAg.lld:pubmed
pubmed-article:11133837pubmed:languageenglld:pubmed
pubmed-article:11133837pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11133837pubmed:citationSubsetIMlld:pubmed
pubmed-article:11133837pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11133837pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11133837pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11133837pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11133837pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11133837pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11133837pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11133837pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11133837pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11133837pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11133837pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11133837pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11133837pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11133837pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11133837pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11133837pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11133837pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11133837pubmed:statusMEDLINElld:pubmed
pubmed-article:11133837pubmed:monthJanlld:pubmed
pubmed-article:11133837pubmed:issn0953-8178lld:pubmed
pubmed-article:11133837pubmed:authorpubmed-author:RevillardJ...lld:pubmed
pubmed-article:11133837pubmed:authorpubmed-author:GenestierLLlld:pubmed
pubmed-article:11133837pubmed:authorpubmed-author:IzeradjeneKKlld:pubmed
pubmed-article:11133837pubmed:issnTypePrintlld:pubmed
pubmed-article:11133837pubmed:volume13lld:pubmed
pubmed-article:11133837pubmed:ownerNLMlld:pubmed
pubmed-article:11133837pubmed:authorsCompleteYlld:pubmed
pubmed-article:11133837pubmed:pagination85-93lld:pubmed
pubmed-article:11133837pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11133837pubmed:meshHeadingpubmed-meshheading:11133837...lld:pubmed
pubmed-article:11133837pubmed:meshHeadingpubmed-meshheading:11133837...lld:pubmed
pubmed-article:11133837pubmed:meshHeadingpubmed-meshheading:11133837...lld:pubmed
pubmed-article:11133837pubmed:meshHeadingpubmed-meshheading:11133837...lld:pubmed
pubmed-article:11133837pubmed:meshHeadingpubmed-meshheading:11133837...lld:pubmed
pubmed-article:11133837pubmed:meshHeadingpubmed-meshheading:11133837...lld:pubmed
pubmed-article:11133837pubmed:meshHeadingpubmed-meshheading:11133837...lld:pubmed
pubmed-article:11133837pubmed:meshHeadingpubmed-meshheading:11133837...lld:pubmed
pubmed-article:11133837pubmed:meshHeadingpubmed-meshheading:11133837...lld:pubmed
pubmed-article:11133837pubmed:meshHeadingpubmed-meshheading:11133837...lld:pubmed
pubmed-article:11133837pubmed:meshHeadingpubmed-meshheading:11133837...lld:pubmed
pubmed-article:11133837pubmed:meshHeadingpubmed-meshheading:11133837...lld:pubmed
pubmed-article:11133837pubmed:meshHeadingpubmed-meshheading:11133837...lld:pubmed
pubmed-article:11133837pubmed:meshHeadingpubmed-meshheading:11133837...lld:pubmed
pubmed-article:11133837pubmed:meshHeadingpubmed-meshheading:11133837...lld:pubmed
pubmed-article:11133837pubmed:meshHeadingpubmed-meshheading:11133837...lld:pubmed
pubmed-article:11133837pubmed:meshHeadingpubmed-meshheading:11133837...lld:pubmed
pubmed-article:11133837pubmed:meshHeadingpubmed-meshheading:11133837...lld:pubmed
pubmed-article:11133837pubmed:meshHeadingpubmed-meshheading:11133837...lld:pubmed
pubmed-article:11133837pubmed:meshHeadingpubmed-meshheading:11133837...lld:pubmed
pubmed-article:11133837pubmed:meshHeadingpubmed-meshheading:11133837...lld:pubmed
pubmed-article:11133837pubmed:meshHeadingpubmed-meshheading:11133837...lld:pubmed
pubmed-article:11133837pubmed:meshHeadingpubmed-meshheading:11133837...lld:pubmed
pubmed-article:11133837pubmed:meshHeadingpubmed-meshheading:11133837...lld:pubmed
pubmed-article:11133837pubmed:meshHeadingpubmed-meshheading:11133837...lld:pubmed
pubmed-article:11133837pubmed:meshHeadingpubmed-meshheading:11133837...lld:pubmed
pubmed-article:11133837pubmed:meshHeadingpubmed-meshheading:11133837...lld:pubmed
pubmed-article:11133837pubmed:year2001lld:pubmed
pubmed-article:11133837pubmed:articleTitleInhibition of thymidine synthesis by folate analogues induces a Fas-Fas ligand-independent deletion of superantigen-reactive peripheral T cells.lld:pubmed
pubmed-article:11133837pubmed:affiliationLaboratory of Immunopharmacology, Institut National de la Santé et de la Recherche Médicale U503, Claude Bernard University, Hopital E. Herriot, 5 Place d'Arsonval, 69437 Lyon Cedex 03, France.lld:pubmed
pubmed-article:11133837pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11133837pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed